Navigation Links
Key Findings from Social Media and Email Best Practices Guide for Marketing to Life Scientists

Arlington, VA (PRWEB) November 07, 2013

Digital Marketing to Life Scientists: Social Media and Email Best Practices (13-007) — Get free dataset with report purchase until November 22, 2013

BioInformatics LLC has been tracking scientists’ online usage and preferences for more than a decade. In a continued effort to monitor how researchers are using the Internet to find out about products and services, Digital Marketing to Life Scientists: Social Media and Email Best Practices explores the explosive rise of social media and the enduring value of email.

According to the study, one-third of scientists engage in social media either weekly or daily to support their research. And some scientists are constantly using social media for non-work related activities, which indicates that they are also more likely to spend time on social media sites to support their research.

The desire to connect with friends and colleagues appears to be more pronounced in researchers who live outside North America and Europe. These scientists spend significantly more time engaged in social media both professionally and personally, engaging in social media activities about 2.8 hours per day compared to scientists in North America and in Europe, who spend about two hours per day.

"Life scientists have a more favorable view of vendor participation in social media now than they did in 2011—and they are more likely to think that the interaction has been constructive," says Robin Rothrock, Ph.D., Director of Publications at BioInformatics LLC. Dr. Rothrock adds: "And while it comes as no surprise that scientific peers are thought to provide more reliable, credible information through social media compared to vendors, vendors can actually take advantage of this preference when developing or seeking content for their social media sites by highlighting customer-generated results and posting testimonials from satisfied researchers."

To learn more about Digital Marketing to Life Scientists: Social Media and Email Best Practices (13-007), a complimentary report brochure is available at:

Free Report Brochure


BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 73,000 life scientists, we have supported more than 500 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information contact:

Angela Fernandez
Marketing Coordinator
BioInformatics, LLC
2111 Wilson Blvd., Suite 250
Arlington, VA 22201
703.778.3080 x14 (phone)

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
2. 23andMe Presents Top Ten Most Interesting Genetic Findings of 2011
3. Live Press Briefing on Findings of Biomedical Industry CEO Survey
4. GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
5. Expanded Findings for FirstMarks Completed Clinical Study for Predicting Near-Term (2-3 Years) MI
6. Profil Institute Continues to Publish New Findings in Metabolic Research
7. New Findings of Daily Consumption of Soy Isoflavones and Cacao-Flavonoids in Diabetes Type 2 Patients
8. Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardiums New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart
9. Findings could be used to engineer organs
10. ENDECE Neural to Present Findings at 2013 Biotech Showcase on NDC-1308 which Induces Remyelination of Demyelinated Axons
11. Fertility Associates of Memphis, World-Renowned Expert in Infertility, Presents Findings to European Conference
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... today that it has closed the sale of its ... Guerbet (GBT- NYSE Euronext) in a transaction valued at ... manufacturing facilities and a total of approximately 1,000 employees ... St. Louis area. This entire ...
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. ... (Nasdaq: HART ), a biotechnology company developing bioengineered ... Jim McGorry will present at the LD ... 2015 at 2:30 p.m. PT. The presentation will be ... 30 days. Management will also be available at the ...
Breaking Biology Technology:
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
(Date:11/10/2015)... About signature verification Signature ... identify and verify the identity of an individual ... secure and accurate method of authentication and is ... because each individual,s signature is highly unique. Signature ... signature of an individual is compared and matched ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):